Daniel Chang

Publications

• Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer
  Wu, A. J., Bosch, W. R., Chang, D. T., Hong, T. S., Jabbour, S. K., & Goodman, K. A. (2015). Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(4), 911-920.
• Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy
  Pollom, E. L., Deng, L., Pai, R. K., Brown, J. M., Giaccia, A., & Chang, D. T. (2015). Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 568-576.
• Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.
  Pollom, E. L., Deng, L., Pai, R. K., Brown, J. M., Giaccia, A., & Chang, D. T. (2015). Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. International journal of radiation oncology, biology, physics, 92(3), 568-576.
• Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. Kozak, M. M., von Eyben, R., Pai, J., Vossler, S. R., Limaye, M., & Chang, D. T. (2015). Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. Journal of clinical pathology, 68(5), 341-345.
  
• Survival benefit for adjuvant radiation therapy in minor salivary gland cancers. Zeidan, Y. H., Pekelis, L., An, Y., Holsinger, F. C., Kong, C. S., & Le, Q.-T. (2015). Survival benefit for adjuvant radiation therapy in minor salivary gland cancers. Oral oncology, 51(5), 438-445.
  
• Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary Tract Osmundson, E. C., Wu, Y., Luxton, G., Bazan, J. G., Koong, A. C., & Chang, D. T. (2015). Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary Tract. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(5), 986-994.
  
• Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma Herman, J. M., Chang, D. T., Goodman, K. A., Dholakia, A. S., Raman, S. P., & Koong, A. C. (2015). Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma. CANCER, 121(7), 1128-1137.
  
• Stereotactic body radiation therapy in pancreatic cancer: the new frontier Moningi, S., Marciscano, A. E., Rosati, L. M., Ng, S. K., Forbang, R. T., & Herman, J. M. (2014). Stereotactic body radiation therapy in pancreatic cancer: the new frontier. EXPERT REVIEW OF ANTICANCER THERAPY, 14(12), 1461-1475.
  
• Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., & Chang, D. T. (2014). Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(4), 918-925.
  
• LEF-1 is Frequently Expressed in Colorectal Carcinoma and Not in Other Gastrointestinal Tract Adenocarcinomas: An Immunohistochemical Survey of 602 Gastrointestinal Tract Neoplasms Kermanshahi, T. R., Jayachandran, P., Chang, D. T., & Pai, R. (2014). LEF-1 is Frequently Expressed in Colorectal Carcinoma and Not in Other Gastrointestinal Tract Adenocarcinomas: An Immunohistochemical Survey of 602 Gastrointestinal Tract Neoplasms. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 22(10), 728-734.
  
• Dosimetric Modeling of Central Liver Toxicity After SBRT to the Liver Osmundson, E., Wu, Y., Bazan, J. G., Koong, A. C., & Chang, D. T. (2014). Dosimetric Modeling of Central Liver Toxicity After SBRT to the Liver. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S382-S382.
  
• Hepatobiliary Cancers, Version 2.2014 Benson, A. B., D'Angelica, M. I., Abrams, T. A., Are, C., Bloomston, P. M., & Sundar, H. (2014). Hepatobiliary Cancers, Version 2.2014. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(8), 1152-1182.
  
• Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy Dholakia, A. S., Chaudhry, M., Leal, J. P., Chang, D. T., Raman, S. P., & Herman, J. M. (2014). Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(3), 539-546.
  
• Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma Shultz, D. B., Chan, C., Shaffer, J. L., Kunz, P. L., Koong, A. C., & Chang, D. T. (2014). Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma. PANCREAS, 43(5), 777-783.
  
• High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-ß1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Cheng, J. Ch., Graber, M. S., Hsu, F.-M., Tsai, C.-L., Castaneda, L., & Koong, A. C. (2014). High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-ß1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Annals of surgical oncology, 21(7), 2361-2368.
  
• Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer Trakul, N., Koong, A. C., & Chang, D. T. (2014). Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer. SEMINARS IN RADIATION ONCOLOGY, 24(2), 140-147.
  
• Stereotactic body radiotherapy in the treatment of pancreatic cancer. Trakul, N., Koong, A. C., & Chang, D. T. (2014). Stereotactic body radiotherapy in the treatment of pancreatic cancer. Seminars in radiation oncology, 24(2), 140-147.
  
• Combined-modality Therapy for Rectal Cancer Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race Tonlaar, N., Song, S., Hong, J. C., Minsky, B. D., Chang, D. T., & Liauw, S. L. (2014). Combined-modality Therapy for Rectal Cancer Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 37(2), 122-125.
  
• False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Paudel, N., Kunz, P. L., Poultsides, G. A., Koong, A. C., & Chang, D. T. (2014). False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer. Practical radiation oncology, 4(6), 368-371.
  
• In reply to Leung. Chang, D. T., Haffty, B. G., & Wilson, L. D. (2014). In reply to Leung. International journal of radiation oncology, biology, physics, 88(1), 241-242.
  
• Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., & Chang, D. T. (2013). Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(5), 983-991.
  
• Cone beam CT imaging with limited angle of projections and prior knowledge for volumetric verification of non-coplanar beam radiation therapy: a proof of concept study Meng, B., Xing, L., Han, B., Koong, A., Chang, D., & Li, R. (2013). Cone beam CT imaging with limited angle of projections and prior knowledge for volumetric verification of non-coplanar beam radiation therapy: a proof of concept study. PHYSICS IN MEDICINE AND BIOLOGY, 58(21), 7777-7789.
  
• Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis Hong, J. C., Murphy, J. D., Wang, S. J., Koong, A. C., & Chang, D. T. (2013). Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis. ANNALS OF SURGICAL ONCOLOGY, 20(12), 3999-4007.
  
• Factors that Determine Academic Versus Private Practice Career Interest in Radiation Oncology Residents in the United States: Results of a Nationwide Survey Chang, D. T., Shaffer, J. L., Haffty, B. G., & Wilson, L. D. (2013). Factors that Determine Academic Versus Private Practice Career Interest in Radiation Oncology Residents in the United States: Results of a Nationwide Survey. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(3), 464-470.
  
• Long-Term Outcomes of Surgery Followed by Radiation Therapy for Minor Salivary Gland Carcinomas Zeidan, Y. H., Shultz, D. B., Murphy, J. D., Chan, C., Kaplan, M. J., & Le, Q.-T. (2013). Long-Term Outcomes of Surgery Followed by Radiation Therapy for Minor Salivary Gland Carcinomas. LARYNGOSCOPE, 123(11), 2675-2680.
  
• Clinicopathologic Features of Synchronous Colorectal Carcinoma A Distinct Subset Arising From Multiple Sessile Serrated Adenomas and Associated With High Levels of Microsatellite Instability and Favorable Prognosis Hu, H., Chang, D. T., Nikiforova, M. N., Kuan, S.-F., & Pai, R. K. (2013). Clinicopathologic Features of Synchronous Colorectal Carcinoma A Distinct Subset Arising From Multiple Sessile Serrated Adenomas and Associated With High Levels of Microsatellite Instability and Favorable Prognosis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(11), 1660-1670.
  
• Safety of Y-90 Radioembolization in Patients Who Have Undergone Previous External Beam Radiation Therapy Lam, M. Geh., Abdelmaksoud, M. Hk., Chang, D. T., Eclov, N. C., Chung, M. P., & Sze, D. Y. (2013). Safety of Y-90 Radioembolization in Patients Who Have Undergone Previous External Beam Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), 323-329.
  
• Radiotherapy for nonadenoid cystic carcinomas of major salivary glands Chung, M. P., Tang, C., Chan, C., Hara, W. Y., Loo, B. W., & Chang, D. T. (2013). Radiotherapy for nonadenoid cystic carcinomas of major salivary glands. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 34(5), 425-430.
  
• Signet Ring Cell Colorectal Carcinoma A Distinct Subset of Mucin-poor Microsatellite-stable Signet Ring Cell Carcinoma Associated With Dismal Prognosis Hartman, D. J., Nikiforova, M. N., Chang, D. T., Chu, E., Bahary, N., & Pai, R. K. (2013). Signet Ring Cell Colorectal Carcinoma A Distinct Subset of Mucin-poor Microsatellite-stable Signet Ring Cell Carcinoma Associated With Dismal Prognosis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(7), 969-977.
  
• Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement? Patel, M. I., Rhoads, K. F., Ma, Y., Ford, J. M., Visser, B. C., & Poultsides, G. A. (2013). Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement?. ANNALS OF SURGICAL ONCOLOGY, 20(5), 1631-1638.
  
• A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma. Wild, A. T., Chang, D. T., Goodman, K. A., Laheru, D. A., Zheng, L., & Herman, J. M. (2013). A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma. Practical radiation oncology, 3(2), S4-5.
  
• Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer Taniguchi, C. M., Murphy, J. D., Eclov, N., Atwood, T. F., Phd, K. Nk., & Chang, D. T. (2013). Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85(4), 1090-1095.
  
• Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy Solanki, A. A., Chang, D. T., & Liauw, S. L. (2013). Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy. ONCOTARGETS AND THERAPY, 6, 1097-1110.
  
• Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Koong, A. C., Kapp, D. S., Quon, A., Graves, E. E., & Chang, D. T. (2013). Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal. JOURNAL OF NUCLEAR MEDICINE, 54(1), 27-32.
  
• Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Luxton, G., Mok, E. C., Koong, A. C., & Chang, D. T. (2012). Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), 700-706.
  
• Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., & Chang, D. T. (2012). Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S350-S350.
  
• SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series Wild, A., Hiniker, S. M., LIMAYE, M. R., Chang, D. T., Laheru, D. A., & Herman, J. M. (2012). SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S323-S323.
  
• Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer Jayachandran, P., Pai, R. K., Quon, A., Graves, E., Krakow, T. E., & Chang, D. T. (2012). Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(2), 471-477.
  
• Esophageal tolerance to high-dose stereotactic ablative radiotherapy Abelson, J. A., Murphy, J. D., Loo, B. W., Chang, D. T., Daly, M. E., & Gibbs, I. C. (2012). Esophageal tolerance to high-dose stereotactic ablative radiotherapy. DISEASES OF THE ESOPHAGUS, 25(7), 623-629.
  
• Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Chennupati, S. K., Quon, A., Kamaya, A., Pai, R. K., La, T., & Chang, D. T. (2012). Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 334-339.
  
• Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images Li, R., Mok, E., Chang, D. T., Daly, M., Loo, B. W., & Xing, L. (2012). Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), E709-E715.
  
• Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes Chu, K. P., Murphy, J. D., La, T. H., Krakow, T. E., Iagaru, A., & Quynh-Thu Le, Q. T. (2012). Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), 1521-1527.
  
• Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence Song, S., Hong, J. C., McDonnell, S. E., Koong, A. C., Minsky, B. D., & Liauw, S. L. (2012). Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence. ANNALS OF SURGICAL ONCOLOGY, 19(8), 2471-2476.
  
• Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features Chang, D. T., Pai, R. K., Rybicki, L. A., DiMaio, M. A., Limaye, M., & Pai, R. K. (2012). Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. MODERN PATHOLOGY, 25(8), 1128-1139.
  
• Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer Daly, M. E., Kapp, D. S., Maxim, P. G., Welton, M. L., Tran, P. T., & Chang, D. T. (2012). Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer. DISEASES OF THE COLON & RECTUM, 55(6), 695-702.
  
• A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma Herman, J. M., Chang, D. T., Goodman, K. A., Wild, A. T., Laheru, D., & Koong, A. (2012). A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY, 30(15).
  
• Intensity-Modulated Radiotherapy for Tumors of the Nasal Cavity and Paranasal Sinuses: Clinical Outcomes and Patterns of Failure Wiegner, E. A., Daly, M. E., Murphy, J. D., Abelson, J., Chapman, C. H., & Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Tumors of the Nasal Cavity and Paranasal Sinuses: Clinical Outcomes and Patterns of Failure. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(1), 243-251.
  
• BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features Pai, R. K., Jayachandran, P., Koong, A. C., Chang, D. T., Kwok, S., & Pai, R. K. (2012). BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(5), 744-752.
  
• Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., & Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E595-E601.
  
• Modern Radiation Therapy Techniques for Pancreatic Cancer Trakul, N., Koong, A. C., Maxim, P. G., & Chang, D. T. (2012). Modern Radiation Therapy Techniques for Pancreatic Cancer. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 41(1), 223-?.
  
• Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer Murphy, J. D., Chang, D. T., Abelson, J., Daly, M. E., Yeung, H. N., & Koong, A. C. (2012). Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. CANCER, 118(4), 1119-1129.
  
• HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population: Clinicopathologic Analysis With Proposed Approach to HER2 Assessment Kunz, P. L., Mojtahed, A., Fisher, G. A., Ford, J. M., Chang, D. T., & Pai, R. K. (2012). HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population: Clinicopathologic Analysis With Proposed Approach to HER2 Assessment. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(1), 13-24.
  
• Combined-modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race. Tonlaar, N., Song, S., Hong, J. C., Minsky, B. D., Chang, D. T., & Liauw, S. L. (2012). Combined-modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race. American journal of clinical oncology.
  
• A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male. Wanta, S. M., Basina, M., Chang, S. D., Chang, D. T., Ford, J. M., & Kunz, P. L. (2011). A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male. Rare tumors, 3(4).
  
• SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER Schellenberg, D., Kim, J., Ciristman-Skieller, C., Chun, C. L., Columbo, L. A., & Koong, A. C. (2011). SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(1), 181-188.
  
• Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis Chang, D. T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A. C., & Schefter, T. E. (2011). Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis. CANCER, 117(17), 4060-4069.
  
• Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Hara, W., Hsu, A., Kunz, P. A., Ford, J., & Chang, D. T. (2011). Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. CANCER, 117(15), 3342-3351.
  
• INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA: PATTERNS OF FAILURE AND PREDICTORS OF LOCAL CONTROL Daly, M. E., Quynh-Thu Le, Q. T., Kozak, M. M., Maxim, P. G., Murphy, J. D., & Chang, D. T. (2011). INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA: PATTERNS OF FAILURE AND PREDICTORS OF LOCAL CONTROL. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 80(5), 1412-1422.
  
• Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy? Daly, M. E., Murphy, J. D., Mok, E., Christman-Skieller, C., Koong, A. C., & Chang, D. T. (2011). Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy?. Practical radiation oncology, 1(2), 85-94.
  
• PROSPECTIVE RANDOMIZED DOUBLE-BLIND PILOT STUDY OF SITE-SPECIFIC CONSENSUS ATLAS IMPLEMENTATION FOR RECTAL CANCER TARGET VOLUME DELINEATION IN THE COOPERATIVE GROUP SETTING Fuller, C. D., Nijkamp, J., Duppen, J. C., Rasch, C. Rn., Thomas, C. R., & Kachnic, L. A. (2011). PROSPECTIVE RANDOMIZED DOUBLE-BLIND PILOT STUDY OF SITE-SPECIFIC CONSENSUS ATLAS IMPLEMENTATION FOR RECTAL CANCER TARGET VOLUME DELINEATION IN THE COOPERATIVE GROUP SETTING. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(2), 481-489.
  
• Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma: Direct Lymph Node Invasion Has Similar Survival to Node-Negative Disease Pai, R. K., Beck, A. H., Mitchem, J., Linehan, D. C., Chang, D. T., & Pai, R. K. (2011). Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma: Direct Lymph Node Invasion Has Similar Survival to Node-Negative Disease. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 35(2), 228-234.
  
• INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX Daly, M. E., Le, Q.-T., Jain, A. K., Maxim, P. G., Hsu, A., & Chang, D. T. (2011). INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 33(1), 103-111.
  
• Gastrointestinal Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy Murphy, J. D., Abelson, J., Chung, M. P., Chang, D. T., & Koong, A. C. (2011). Gastrointestinal Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S378-S378.
  
• Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation Vossler, S. R., Bavan, B., Kunz, P., Ford, J. M., Fisher, G. A., & Chang, D. T. (2011). Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S309-S309.
  
• Radiotherapy For Adenoid Cystic Carcinomas Of The Head and Neck: Clinical Outcomes And Patterns Of Failure Shultz, D. B., Murphy, J. D., Daly, M. E., Hara, W., Le, Q. T., & Chang, D. T. (2011). Radiotherapy For Adenoid Cystic Carcinomas Of The Head and Neck: Clinical Outcomes And Patterns Of Failure. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S528-S528.
  
• Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer Atwood, T. F., Mok, E., Lo, A., Xing, L., Koong, A. C., & Chang, D. T. (2011). Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S345-S346.
  
• Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies Minn, A. Y., Koong, A. C., & Chang, D. T. (2011). Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies. IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 43, 412-427.
  
• A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER Murphy, J. D., Christman-Skieller, C., Kim, J., Dieterich, S., Chang, D. T., & Koong, A. C. (2010). A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(5), 1420-1426.
  
• Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., & Pai, R. K. (2010). Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma. CANCER, 116(22), 5179-5187.
  
• Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma Bachireddy, P., Tseng, D., Horoschak, M., Chang, D. T., Koong, A. C., & Tran, P. T. (2010). Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma. RADIATION ONCOLOGY, 5.
  
• Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., & Chang, D. T. (2010). Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer. CANCER, 116(16), 3943-3952.
  
• (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION-FREE AND OVERALL SURVIVAL IN LOCALLY ADVANCED PANCREAS CANCER TREATED WITH STEREOTACTIC RADIOTHERAPY Schellenberg, D., Quon, A., Minn, A. Y., Graves, E. E., Kunz, P., & Chang, D. T. (2010). (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION-FREE AND OVERALL SURVIVAL IN LOCALLY ADVANCED PANCREAS CANCER TREATED WITH STEREOTACTIC RADIOTHERAPY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 77(5), 1420-1425.
  
• Pathological response after chemoradiation for T3 rectal cancer. Chennupati, S. K., Kamaya, A., Fisher, G. A., Ford, J. M., Kunz, P., & Chang, D. T. (2010). Pathological response after chemoradiation for T3 rectal cancer. Colorectal disease , 12(7 Online), e24-30.
  
• Pathological response after chemoradiation for T3 rectal cancer Chennupati, S. K., Kamaya, A., Fisher, G. A., Ford, J. M., Kunz, P., & Chang, D. T. (2010). Pathological response after chemoradiation for T3 rectal cancer. COLORECTAL DISEASE, 12(7), E24-E30.
  
• INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER: CLINICAL OUTCOMES AND PATTERNS OF FAILURE Daly, M. E., Le, Q.-T., Maxim, P. G., Loo, B. W., Kaplan, M. J., & Chang, D. T. (2010). INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER: CLINICAL OUTCOMES AND PATTERNS OF FAILURE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 76(5), 1339-1346.
  
• EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy Park, W. G., Yan, B. M., Schellenberg, D., Kim, J., Chang, D. T., & Van Dam, J. (2010). EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. GASTROINTESTINAL ENDOSCOPY, 71(3), 513-518.
  
• INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION Jayachandran, P., Minn, A. Y., Van Dam, J., Norton, J. A., Koong, A. C., & Chang, D. T. (2010). INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 76(2), 603-607.
  
• Multimodality treatment with intensity modulated radiation therapy for esophageal cancer La, T. H., Minn, A. Y., Su, Z., Fisher, G. A., Ford, J. M., & Chang, D. T. (2010). Multimodality treatment with intensity modulated radiation therapy for esophageal cancer. DISEASES OF THE ESOPHAGUS, 23(4), 300-308.
  
• Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis Chang, D. T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A. C., & Schefter, T. E. (2010). Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S56-S57.
  
• Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head and Neck Cancer Outcomes Chu, K. Pm., Murphy, J., La, T. H., Loo, B. W., Krakow, T. E., & Le, Q. (2010). Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head and Neck Cancer Outcomes. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S460-S460.
  
• Combined Modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race Liauw, S., Song, S., Tonlaar, N., Hong, J. C., Minsky, B. D., & Polite, B. (2010). Combined Modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S198-S198.
  
• Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer Taniguchi, C. M., Kielar, K. N., Murphy, J. D., Atwood, T. F., Christman-Skieller, C., & Chang, D. T. (2010). Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S329-S329.
  
• Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer Kielar, K. N., Atwood, T. F., Taniguchi, C. M., Christman-Skieller, C., Xing, L., & Chang, D. T. (2010). Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S785-S785.
  
• Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal Bazan, J. G., Hara, W., Kunz, P., Fisher, G. A., Ford, J. M., & Chang, D. T. (2010). Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S300-S301.
  
• Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis Chang, S. T., Zahn, J. M., Horecka, J., Kunz, P. L., Ford, J. M., & Koong, A. C. (2009). Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis. JOURNAL OF TRANSLATIONAL MEDICINE, 7.
  
• Pharmacologically Increased Tumor Hypoxia Can Be Measured by F-18-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104 Cairns, R. A., Bennewith, K. L., Graves, E. E., Giaccia, A. J., Chang, D. T., & Denko, N. C. (2009). Pharmacologically Increased Tumor Hypoxia Can Be Measured by F-18-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104. CLINICAL CANCER RESEARCH, 15(23), 7170-7174.
  
• Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology and End Results Analysis Chang, D. T., Chapman, C., Shen, J., Su, Z., & Koong, A. C. (2009). Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology and End Results Analysis. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 32(4), 405-410.
  
• Pancreatic Tumor Motion on a Single Planning 4D-CT Does Not Correlate With Intrafraction Tumor Motion During Treatment Minn, A. Y., Schellenberg, D., Maxim, P., Suh, Y., McKenna, S., & Koong, A. C. (2009). Pancreatic Tumor Motion on a Single Planning 4D-CT Does Not Correlate With Intrafraction Tumor Motion During Treatment. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 32(4), 364-368.
  
• Long-term Outcomes for Stage I-II Aggressive Non-Hodgkin Lymphoma of Waldeyer's Ring Chang, D. T., Mendenhall, N. P., Lynch, J. W., Morris, C. G., & Olivier, K. R. (2009). Long-term Outcomes for Stage I-II Aggressive Non-Hodgkin Lymphoma of Waldeyer's Ring. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 32(3), 233-237.
  
• Percutaneous Implantation of Fiducial Markers for Imaging-Guided Radiation Therapy Kothary, N., Dieterich, S., Louie, J. D., Chang, D. T., Hofmann, L. V., & Sze, D. Y. (2009). Percutaneous Implantation of Fiducial Markers for Imaging-Guided Radiation Therapy. AMERICAN JOURNAL OF ROENTGENOLOGY, 192(4), 1090-1096.
  
• Xerostomia in Long-term Survivors of Aggressive Non-Hodgkin's Lymphoma of Waldeyer's Ring A Potential Role for Parotid-Sparing Techniques? Chang, D. T., Amdur, R. J., Pacholke, H., Mendenhall, N. P., Morris, C. G., & Olivier, K. R. (2009). Xerostomia in Long-term Survivors of Aggressive Non-Hodgkin's Lymphoma of Waldeyer's Ring A Potential Role for Parotid-Sparing Techniques?. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 32(2), 145-149.
  
• Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy Kothary, N., Heit, J. J., Louie, J. D., Kuo, W. T., Loo, B. W., & Hofmann, L. V. (2009). Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 20(2), 235-239.
  
• Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K. A., & Koong, A. C. (2009). Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas. CANCER, 115(3), 665-672.
  
• A Prospective Randomized Pilot Study of Site-specific Atlas Incorporation into Target Volume Delineation Instructions in the Cooperative Group Setting: Preliminary Results from a Southwest Oncology Group Pilot using Big Brother Fuller, C. D., Duppen, J., Rasch, C. Rn., Kachnic, L., Wang, S. J., & Thomas, C. R. (2009). A Prospective Randomized Pilot Study of Site-specific Atlas Incorporation into Target Volume Delineation Instructions in the Cooperative Group Setting: Preliminary Results from a Southwest Oncology Group Pilot using Big Brother. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(3), S136-S137.
  
• Stereotactic body radiotherapy for unresectable adenocarcinoma of the pancreas Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K., & Koong, A. (2008). Stereotactic body radiotherapy for unresectable adenocarcinoma of the pancreas. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 72(1), S249-S249.
  
• Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Chang, D. T., Sandow, P. R., Morris, C. G., Hollander, R., Scarborough, L., & Mendenhall, W. M. (2007). Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 29(6), 528-536.
  
• Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: The importance of radiation field selection Chang, D. T., Feigenberg, S. J., Indelicato, D. J., Morris, C. G., Lightsey, J., & Mendenhall, N. P. (2007). Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: The importance of radiation field selection. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 67(4), 1043-1051.
  
• Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer Chang, D., Liu, C., Dempsey, J. F., Palta, J. R., Kopea, J., & Olivier, K. R. (2007). Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30(1), 57-62.
  
• Adjuvant radiotherapy for cutaneous melanoma: Comparing hypofractionation to conventional fractionation Chang, D. T., Amdur, R. J., Morris, C. G., & Mendenhall, W. M. (2006). Adjuvant radiotherapy for cutaneous melanoma: Comparing hypofractionation to conventional fractionation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(4), 1051-1055.
  
• The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis Chang, D. T., Olivier, K. R., Morris, C. G., Liu, C., Dempsey, J. F., & Palta, J. R. (2006). The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 65(1), 125-131.
  
• Re-examining the role of elective nodal irradiation - Finding ways to maximize the therapeutic ratio Chang, D. T., Zlotecki, R. A., & Olivier, K. R. (2005). Re-examining the role of elective nodal irradiation - Finding ways to maximize the therapeutic ratio. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 28(6), 597-602.
  
• Merkel cell carcinoma of the skin with leptomeningeal metastases Chang, D. T., Mancuso, A. A., Riggs, C. E., & Mendenhall, W. M. (2005). Merkel cell carcinoma of the skin with leptomeningeal metastases. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 26(3), 210-213.
  
• Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors Chen, F., Chang, D., Goh, M., Klibanov, S. A., & Ljungman, M. (2000). Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. CELL GROWTH & DIFFERENTIATION, 11(5), 239-246.
  
• Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest Chang, D., Chen, F., Zhang, F. F., McKay, B. C., & Ljungman, M. (1999). Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest. CELL GROWTH & DIFFERENTIATION, 10(3), 155-162.